Kyrgyzstan vs Suriname: Cause of death, by non-communicable diseases, ages 0-4, male
Kyrgyzstan
22.5%
in 2021
Suriname
22.7%
in 2021
Kyrgyzstan rank
122nd
Suriname rank
120th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Kyrgyzstan
- Suriname
How they compare
Suriname currently reports 22.7% against 22.5% in Kyrgyzstan, a difference of 0.2%.
Across all 6 years both countries report, Suriname has been ahead every year.
Kyrgyzstan ranks 122nd and Suriname ranks 120th of 185 countries.
Suriname has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kyrgyzstan | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.6% | 19.0% | 7.4% | Suriname |
| 2010s | 19.5% | 23.8% | 4.3% | Suriname |
| 2020s | 22.4% | 22.9% | 0.5% | Suriname |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Kyrgyzstan or Suriname?
- Suriname, at 22.7% against 22.5% in Kyrgyzstan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Kyrgyzstan and Suriname?
- 0.2%, with Suriname ahead.
- How many years of comparable data are there for Kyrgyzstan and Suriname?
- 6 years are reported by both, from 2000 to 2021.
- How do Kyrgyzstan and Suriname rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Kyrgyzstan ranks 122nd and Suriname ranks 120th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.